Abstract:Background Previous findings indicated that polymorphism in gene catechol-O-methyltransferase (COMT) had been linked to chemotherapy-related cognitive impairment (CRCI). Nevertheless, the motivation of COMT polymorphisms in regulating cognitive impairment in breast cancer survivors with disparate status of human epidermal growth factor receptor 2 (HER2) was still vague. Objective The current research aimed to evaluate the regulation of the risk by COMT genotype on CRCI in breast cancer survivors with disparate status of HER2. Methods Breast cancer survivors (103 with HER2− and 118 with HER2+) underwent neuropsychological tests before and after chemotherapy, containing event- and time-based prospective memory (EBPM and TBPM). Three single-nucleotide polymorphisms (SNPs) were estimated by providing peripheral blood, containing COMT (rs165599, rs737865, and rs4680). Results The EBPM and TBPM performances was lower as compared with these before chemotherapy (z = −7.712, z = −2.403, respectively, p < 0.01). Furthermore, the EBPM and TBPM performances of HER2− group survivors were lower than those of HER2+ group survivors after chemotherapy (z = −7.181, p < 0.01; z = −2.205 p < 0.05, respectively). The survivors with COMT (rs165599) A/A genotype carriers had a meaningfully poorer chance of memory descend [dominant model: adjusted, OR = 2.21, CI (95%) = 1.156–4.225, p = 0.016] and showed better on TBPM test, relative to G/G genotype. Patients with the COMT (rs737865) A/G and G/G genotype showed protective function than the patients with the A/A and performed better on MMSE and TBPM tests. Conclusion The types of HER2 may be correlated to chemotherapy-related prospective memory impairments in breast cancer survivors. Furthermore, the COMT (rs165599, rs737865) polymorphisms were correlated to the risk of TBPM decline scores and possibly be a potential genetic identifying for increasing risk of CRCI in breast cancer patients with disparate status of HER2.

Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women

CYP2E1 T7632A and 9-Bp Insertion Polymorphisms and Colorectal Cancer Risk: a Meta-Analysis Based on 4,592 Cases and 5,918 Controls

Association Between the LINC00673 Rs11655237 C> T Polymorphisms with Cancer Risk in the Chinese Population: A Meta-Analysis

[Association Between Genetic Polymorphisms of Metabolic Enzymes and Susceptibility of Colorectal Cancer].

[Prevalence of Val158Met Polymorphism in COMT Gene on Non-Brca1/2 Hereditary Breast Cancer].

[A Case-Control Study on the Association Between Genetic Polymorphisms of Metabolic Enzymes and the Risk of Colorectal Cancer].

Relationship between metabolic enzyme polymorphism and colorectal cancer.

[Association of XPC gene polymorphisms with breast cancer risk].

A Multigenic Study on Breast Cancer Risk Associated with Genetic Polymorphisms of ER Alpha , COMT and CYP19 Gene in BRCA1/BRCA2 Negative Shanghai Women with Early Onset Breast Cancer or Affected Relatives

Association between the COMT Val158Met polymorphism and risk of cancer: evidence from 99 case-control studies.

Lack of Association Between the COMT Rs4680 Polymorphism and Ovarian Cancer Risk: Evidence from a Meta-analysis of 3,940 Individuals

Contribution of Catechol-O-Methyltransferase Val158met Polymorphism to Endometrial Cancer Risk in Postmenopausal Women: A Meta-Analysis

Association of CYP2C19*3 Gene Polymorphism with Breast Cancer in Chinese Women.

CYP17 Polymorphisms Are Associated with Decreased Risk of Breast Cancer in Chinese Han Women: a Case-Control Study

The Association Of Cyp2d6 Star 10 Polymorphism With Breast Cancer Risk And Clinico-Pathologic Characteristics In Chinese Women

Association of CYP2D6*10 (c.100c>t) Polymorphisms with Clinical Outcome of Breast Cancer after Tamoxifen Adjuvant Endocrine Therapy in Chinese Population.

The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2−/+ Breast Cancer

The Association of CASC16 Variants with Breast Cancer Risk in a Northwest Chinese Female Population

Cytochrome P450 1A1 (CYP1A1) T3801C and A2455G Polymorphisms in Breast Cancer Risk: a Meta-Analysis

Polymorphisms inCYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women

Nucleotide Excision Repair Pathway Gene Polymorphisms Are Linked to Breast Cancer Risk in a Chinese Population